Longevity Clinic Finder logo
Find Clinics
Browse Locations
Browse ServicesGuidesEvents
Register Your ClinicRegister ClinicSign In
Find ClinicsBrowse LocationsBrowse ServicesGuidesEvents
For Providers
Claim Your Clinic (Free)Upgrade Your VisibilityProvider Login
Register Your ClinicSign In
  1. Home
  2. Guides
  3. Treatments
  4. Sexual Wellness
Longevity Clinic Finder logo

A global directory connecting individuals with longevity, wellness, and preventive health clinics. Discover treatments, explore providers, and find clinics near you or around the world.

  • Genitourinary Syndrome of Menopause Care
  • Sexual Wellness

    Genitourinary Syndrome of Menopause Care

    GSM care starts with moisturizers and lubricants, then local hormones when needed. Energy devices have weaker evidence and are not first-line treatment.

    Written by LCF Staff3 min readUpdated October 5, 2026

    Educational Guidance Notice

    This dossier is published for general educational reference and biomarker understanding only. It does not constitute individual medical diagnosis or care. Longevity Clinic Finder does not deliver direct clinical therapy. Consult an accredited board-certified physician before booking Sexual Wellness.

    Review Medical Disclaimers →
    Genitourinary Syndrome of Menopause Care

    Overview

    Genitourinary syndrome of menopause (GSM) describes bothersome vulvovaginal, sexual, and some urinary symptoms linked to lower estrogen and androgen effects on the genitourinary tract. Dryness, burning, irritation, pain with sex, and recurrent urinary complaints are common and often underdiagnosed. Care is a clinical service, not a spa “rejuvenation.” The North American Menopause Society (now The Menopause Society, NAMS) states that first-line therapy for many women is nonhormone lubricants with sexual activity and regular long-acting vaginal moisturizers. For moderate to severe GSM, or symptoms that persist, several government-approved options have stronger evidence: low-dose vaginal estrogen, vaginal DHEA (prasterone), oral ospemifene, and systemic estrogen when bothersome vasomotor symptoms are also present.

    The 2025 AUA/SUFU/AUGS guideline likewise supports offering local low-dose vaginal estrogen for dryness, irritation, and dyspareunia, and recommends moisturizers or lubricants alone or with other therapies. Evaluation should distinguish GSM from infection, vulvar dermatoses, pelvic floor pain, medication effects, and malignancy warning signs. Postmenopausal bleeding always requires evaluation, regardless of which GSM product you use.

    Energy-based devices have weaker evidence. NAMS concluded there are insufficient placebo-controlled trials of laser and other energy-based therapies to draw efficacy and safety conclusions or to make treatment recommendations. The FDA has warned against using energy-based devices for “vaginal rejuvenation” or cosmetic vaginal procedures because of burns, scarring, pain with sex, and chronic pain. A cash-pay laser series is not equivalent to an FDA-approved vaginal estrogen, DHEA insert, or ospemifene prescription.

    People with a history of estrogen-dependent breast cancer should start with nonhormonal care. ACOG allows consideration of low-dose vaginal estrogen after shared decision-making if nonhormonal measures fail; aromatase-inhibitor users need the gynecologist and oncologist in that discussion. Systemic menopausal hormone therapy is not required solely for local symptoms and has a different risk profile. Reasonable goals are less dryness and less pain with sex—not a guaranteed return of desire or a cosmetic change.

    • Ask which option is first-line for your symptom severity and cancer history.
    • Do not accept a device package as proven GSM treatment when moisturizers or local hormones have not been discussed.

    Benefits

    Relieves dryness, irritation, and pain with sex when the matched therapy is used consistently
    Starts with nonhormonal moisturizers and lubricants for many mild symptoms
    Offers prescription local estrogen, vaginal DHEA, or ospemifene when symptoms persist
    Separates GSM from infection, skin disease, pelvic floor pain, and bleeding that needs workup
    Avoids treating energy devices as equivalent to approved first-line therapies

    The Procedure

    1

    Evaluate symptoms and red flags

    2

    Start nonhormonal care when appropriate

    3

    Offer approved local therapy if needed

    4

    Address devices and unproven add-ons

    5

    Follow up on response and bleeding

    Preparation

    Write when dryness, pain, or urinary symptoms started and list all hormones, aromatase inhibitors, tamoxifen, and vaginal products. Do not ignore postmenopausal bleeding. Bring oncology records if you have a hormone-sensitive cancer history. Avoid a new over-the-counter steroid or “tightening” cream the day of the exam unless your clinician asked you to use it.

    Recovery & Aftercare

    Moisturizers, lubricants, and most local prescriptions have no downtime. Mild irritation can occur when a product is started; persistent burning, rash, or bleeding should be reported. Device procedures, if you still choose them after counseling, have separate consent and recovery rules and are not required for standard GSM care.

    Risks & Considerations

    Missed infection, dermatosis, or cancer is the main diagnostic harm. Local hormones can cause irritation or spotting; any postmenopausal bleeding needs evaluation. Systemic hormone therapy has different clot, stroke, and cancer considerations and is not required for local symptoms alone. Energy devices can burn or scar and lack strong GSM outcome data. Self-directed compounded hormones from a spa skip monitoring and oncology input.

    Frequently Asked Questions

    References

    [1]

    The Menopause Society (NAMS): 2020 GSM Position Statement (PDF)

    https://menopause.org/docs/default-source/default-document-library/2020-gsm-ps.pdf
    [2]

    The Menopause Society: Genitourinary Syndrome of Menopause (patient)

    https://menopause.org/patient-education/menopause-topics/genitourinary-syndrome-of-menopause
    [3]

    AUA/SUFU/AUGS: Genitourinary Syndrome of Menopause Guideline (2025)

    https://www.auanet.org/guidelines-and-quality/guidelines/genitourinary-syndrome-of-menopause
    [4]

    ACOG: Urogenital Symptoms After Estrogen-Dependent Breast Cancer

    https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2021/12/treatment-of-urogenital-symptoms-in-individuals-with-a-history-of-estrogen-dependent-breast-cancer
    [5]

    Also Known As

    GSM treatmentvaginal atrophy caremenopausal vaginal drynesslocal vaginal estrogenvulvovaginal atrophy treatment

    Quick Facts

    Duration

    The evaluation visit is usually 30–60 minutes; product teaching adds a few minutes.

    Cost Range

    Visit $150–$400; OTC moisturizers and lubricants are inexpensive, while prescription local hormones vary by insurance and device packages are often $1,000–$3,000 cash-pay.

    Frequency

    Moisturizers several times weekly; vaginal estrogen often daily for two weeks then twice weekly; rings every three months; follow-up in 6–12 weeks.

    Explore Clinics

    Find ClinicsBrowse ServicesBrowse by StateBrowse Locations

    Guides

    GuidesEvents

    For Providers

    Claim Your ClinicProvider Sign-inAdvertisePremium Listing & Pricing

    Company

    AboutLCF ScoreContact

    Legal

    AccessibilityPrivacyTerms of ServiceCookie PolicyMedical DisclaimerAll Legal Policies

    © 2026 Longevity Clinic Finder. All rights reserved.

    Designed by SMBPulse

    Your Privacy Choices

    FDA: Warning on energy-based vaginal rejuvenation devices

    https://www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic-procedures-fda-safety-communication

    Ideal Candidates

    Perimenopausal and postmenopausal people with bothersome vulvovaginal, sexual, or selected urinary symptoms after examination. It is not appropriate as a cosmetic “rejuvenation” package, or as the only response to bleeding, a visible lesion, or untreated pelvic pain. Breast-cancer history needs oncology-informed shared decision-making before local hormones.

    Looking for Sexual Wellness?

    Explore nearby clinics, compare profiles, and find providers offering this treatment.

    Find Clinics Near You

    Related Treatment Guides

    • What Is Evidence-Based Sexual Wellness Care?

      Sexual Wellness

    • What Is Sexual Counseling and Sex Therapy?

      Sexual Wellness

    • Pelvic Floor Physical Therapy for Sexual Health

      Sexual Wellness

    Longevity Clinic Finder logo

    A global directory connecting individuals with longevity, wellness, and preventive health clinics. Discover treatments, explore providers, and find clinics near you or around the world.

    Top Cities

    Explore a City
    • Atlanta, GA
    • Austin, TX
    • Boca Raton, FL
    • Charlotte, NC
    • Chicago, IL
    • Colorado Springs, CO
    • Dallas, TX
    • Denver, CO
    • Fort Lauderdale, FL
    • Houston, TX
    • Las Vegas, NV

    Explore Clinics

    Find ClinicsBrowse ServicesBrowse by StateBrowse Locations

    Guides

    GuidesEvents

    For Providers

    Claim Your ClinicProvider Sign-inAdvertisePremium Listing & Pricing

    Company

    AboutLCF ScoreContact

    Legal

    AccessibilityPrivacyTerms of ServiceCookie PolicyMedical DisclaimerAll Legal Policies

    © 2026 Longevity Clinic Finder. All rights reserved.

    Designed by SMBPulse

    Your Privacy Choices
  • Los Angeles, CA
  • Miami, FL
  • Naples, FL
  • Nashville, TN
  • New York, NY
  • Orlando, FL
  • Portland, OR
  • San Antonio, TX
  • San Diego, CA
  • San Francisco, CA
  • Sarasota, FL
  • Scottsdale, AZ
  • Tampa, FL
  • Tucson, AZ